Zobrazeno 1 - 10
of 1 347
pro vyhledávání: '"Overactive Bladder Syndrome"'
Publikováno v:
Perspectives in Clinical Research, Vol 15, Iss 3, Pp 147-151 (2024)
Introduction: Overactive bladder (OAB) syndrome is a chronic disease characterized by urinary urgency with or without urge incontinence, frequency, and nocturia and antimuscarinic drugs such as solifenacin have been the mainstay of treatment. Mirabeg
Externí odkaz:
https://doaj.org/article/37acc67019c242f294fa5dc107ae478c
Autor:
Karl-Erik Andersson
Publikováno v:
Continence, Vol 10, Iss , Pp 101317- (2024)
The history of TRP channels and bladder started in the 1980-ies with the studies of Maggi and collaborators, who created the basis for using capsaicin and other vanilloids in LUT disorders. This narrative review gives a brief history of bladder TRP c
Externí odkaz:
https://doaj.org/article/21f165e4d18845b5bdda5c80cc03b515
Autor:
Yuh-Chen Kuo, Hann-Chorng Kuo
Publikováno v:
Tzu-Chi Medical Journal, Vol 35, Iss 1, Pp 62-68 (2023)
Objectives: To compare the therapeutic efficacy, adverse events (AEs), and patient preference in elderly patients with overactive bladder (OAB) receiving different combinations of mirabegron and solifenacin. Materials and Methods: Elderly OAB patient
Externí odkaz:
https://doaj.org/article/6d87582a85224d838cd4a3f03d552132
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Wang Li, Yanduo Lin, Hong Xie, Qiang Fu, Rong Chen, Xiaoyong Hu, Jianwen Huang, Jihong Wang, Ranxing Yang
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
ObjectivesTo evaluate the effects of mirabegron in the treatment of overactive bladder syndrome (OAB) after radical prostatectomy (RP).Patients and methodsA total of 108 post-operative RP patients were randomly assigned to either the mirabegron (stud
Externí odkaz:
https://doaj.org/article/c292459e0d244a129ebb54259a571883
Autor:
A. Elif Müderrisoglu, Ayse A. Sakul, Sandra Murgas, Jean J. M. C. H. de la Rosette, Martin C. Michel
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Introduction: Pelvic hypoperfusion caused by atherosclerosis has been proposed as a cause of lower urinary tract dysfunction including overactive bladder syndrome (OAB). Limited data indicate that OAB patients with concomitant diabetes or hypertensio
Externí odkaz:
https://doaj.org/article/ce18b18f2595418fa7fee7a0179f06cb
Publikováno v:
Continence, Vol 5, Iss , Pp 100577- (2023)
Mean voided volume (MVV) is a non-invasive indicator of urinary bladder capacity and frequently used as secondary or even primary endpoint in clinical studies of bladder function, particularly in the context of overactive bladder syndrome. We have an
Externí odkaz:
https://doaj.org/article/d0234cf17e15476cbd651236c615e1b8
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
While animal studies have suggested an association between the presence of hypertension and the presence and/or severity of overactive bladder syndrome (OAB) symptoms, little clinical data is available. We have conducted a pre-specified secondary ana
Externí odkaz:
https://doaj.org/article/b9a11be205fa4ffbacc1757615ed52d2
Autor:
Aida Javan Balegh Marand, Cléo Baars, John Heesakkers, Ellen van den Munckhof, Morteza Ghojazadeh, Mohammad Sajjad Rahnama’i, Dick Janssen
Publikováno v:
Life, Vol 13, Iss 5, p 1199 (2023)
Introduction: It has been hypothesized that the urinary microbiome might play an important role in OAB. Studies have been conducted on the association between OAB symptoms and the microbiome, although a possible causality still has to be determined.
Externí odkaz:
https://doaj.org/article/df076f9d659d4ff5bdeef054af39f212